Icahn renews offer to buy Mylan

Carl Icahn is making a new bid to buy Mylan Laboratories, this time offering more than $5 billion for the drug company. He made his first bid for Mylan last fall as he fought against a proposed buyout of King Pharmaceutical. That deal fell apart earlier this year.

- read this story from the Boston Globe for more on the buyout offer

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.